Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › NorthShore Enlists Ambry Genetics for Whole-Exome Sequencing

NorthShore Enlists Ambry Genetics for Whole-Exome Sequencing

Sep 12, 2017
|
staff reporter

This story has been updated to reflect new information from NorthShore regarding its alliance with Invitae.

CHICAGO (GenomeWeb) – NorthShore University HealthSystem is enlisting Ambry Genetics to offer genetic testing and research opportunities, the two entities announced today.

Under the new partnership, Aliso Viejo, California-based Ambry Genetics will provide whole-exome sequencing for 10,000 patients enrolled in NorthShore's Genomic Health Initiative.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jul
15
Featured Webinar

Diagnostic Challenges in Cancer Immunotherapy: An Expert Panel Discussion

Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.

Jul
23
Featured Webinar

Clinical Utility of Liquid Biopsy for the Detection of T790M to Guide Lung Cancer Treatment Strategy

This webinar will discuss a study that set to assess the efficacy and safety of osimertinib in EGFR T790M positive non-small cell lung cancer (NSCLC) patients identified by using plasma sample and cobas EGFR Mutation test v2. This is the first prospective study to use liquid biopsy upfront to evaluate osimertinib efficacy.

What's Popular?

In Molecular Diagnostics

  1. Thermo Fisher Scientific, First Genetics to Develop NGS-Based Diagnostics in Russia

  2. FDA Grants EUA for UCSF, Broad Institute, BioSewoom Coronavirus Tests

  3. FDA Letter Warns About False-Positive Results From Becton Dickinson SARS-CoV-2 Test

  4. Vela Diagnostics Automated Coronavirus Test Gets CE-IVD Mark

  5. SARS-CoV-2 Pandemic May Promote Progress in Paper MDx

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.